Trial Profile

An multicenter, randomized, placebo-controlled Phase 1/2 clinical trial of ADX-246 in healthy volunteers and patients with atopic dermatitis

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 08 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 Jan 2024 According to Aldeyra media release, an IND application has been submitted for a Phase 1 clinical trial in healthy volunteers has been submitted to the FDA and is expected to be expanded to include clinical testing in patients with atopic dermatitis.
21 Dec 2023 New trial record
19 Dec 2023 According to Aldeyra media release, Aldeyra expects to initiate this trial in the first half of 2024. Topline results from the trial are expected in the second half of 2024.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com